As of 30 Sep 2025, 15 institutional investors reported holding $142,653,005 in principal (par value) of GOSSAMER BIO INC - NOTE 5.000% 6/0.
| Period | Principal | Value | Change | Price (% of par) (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | $142,653,005 | $120,891,211 | -$3,069,505 | 69.5% | 15 |
| 2025 Q2 | $151,898,880 | $94,158,395 | -$6,577,712 | 52.47% | 13 |
| 2025 Q1 | $166,276,850 | $106,833,547 | -$1,128,875 | 56.0% | 13 |
| 2024 Q4 | $172,449,850 | $105,507,106 | -$439,371 | 54.0% | 14 |
| 2024 Q3 | $173,427,850 | $91,358,329 | -$505,200 | 52.36% | 14 |
| 2024 Q2 | $174,427,850 | $96,670,884 | -$752,100 | 49.14% | 14 |
| 2024 Q1 | $175,927,850 | $78,772,359 | -$8,738,317,479 | 40.0% | 13 |
| 2023 Q4 | $188,786,978 | $74,291,898 | +$7,178,448 | 37.46% | 13 |
| 2023 Q3 | $169,080,828 | $79,150,972 | +$741,278 | 39.61% | 14 |
| 2023 Q2 | $168,582,983 | $61,664,507 | -$2,951,883 | 30.65% | 14 |
| 2023 Q1 | $195,118,483 | $59,415,969 | -$2,931,177,741 | 27.59% | 17 |
| 2022 Q4 | $210,394,850 | $71,114,924 | -$5,984,440 | 32.35% | 19 |
| 2022 Q3 | $214,009,850 | $226,159,000 | +$9,445,227 | 103.25% | 22 |
| 2022 Q2 | $207,709,350 | $160,778,000 | -$8,295,152 | 74.75% | 20 |
| 2022 Q1 | $208,872,850 | $179,903,000 | -$3,205,034 | 80.61% | 22 |
| 2021 Q4 | $211,460,850 | $220,144,000 | -$934,943 | 98.0% | 24 |
| 2021 Q3 | $209,911,850 | $233,340,000 | +$2,488,375 | 103.87% | 24 |
| 2021 Q2 | $208,037,817 | $180,014,000 | +$10,312,042 | 80.32% | 27 |
| 2021 Q1 | $191,218,741 | $186,885,000 | -$9,186,971,179 | 89.77% | 26 |
| 2020 Q4 | $203,913,665 | $185,676,000 | -$46,482,647 | 90.59% | 25 |
| 2020 Q3 | $208,185,840 | $214,802,000 | +$34,404,317 | 103.05% | 29 |
| 2020 Q2 | $171,712,526 | $170,341,049 | +$170,340,027 | 100.67% | 29 |